Effect of Bromelain , Curcumin and Epigallocatechin in the treatment of outpatient Covid-19 patients
Phase 3
- Conditions
- Covid 19.Pneumonia due to SARS-associated coronavirusJ12.81
- Registration Number
- IRCT20210724051971N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
New 2019 Corona-virus infection (COVID-19) confirmed by rt-PCR test referred to an outpatient clinic
Aged over 18 years
Exclusion Criteria
severe infection needing hospitalization according to the diagnosis of infectious disease specialist
History of allergies to green tea, pineapple, latex and turmeric
history of peptic ulcer in the last 6 months
active bleeding (except for menstrual period )
hepatic or renal failure
coagulopathies
autoimmune disease
pregnancy
cholelithiasis
administration of anti platelet or anticoagulant agents (except aspirin)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method